Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Medical Genetics

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jmg.39.4.243PMID 11950850PMCID PMC1735083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemically Induced Birth Defects

  2002cited by this paper
• Association of prenatal phenobarbital and phenytoin exposure with genital anomalies and menstrual disorders.

  2001cited by this paper
• Polycystic Ovarian Syndrome in Women with Epilepsy: A Review

  2001cited by this paper
• The teratogenicity of anticonvulsant drugs.

  2001cited by this paper
• Additional educational needs in children born to mothers with epilepsy

  2001cited by this paper
• Anticonvulsant Use During Lactation

  2000cited by this paper
• Patients' perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy.

  2000cited by this paper
• Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population‐based study

  2000cited by this paper
• Developing diagnostic criteria for the fetal anticonvulsant syndromes.

  2000cited by this paper
• Intelligence and physical features of children of women with epilepsy.

  2000cited by this paper
• Effect of anti-epileptic drugs on intrauterine growth.

  2000cited by this paper
• Digit effects produced by prenatal exposure to antiepileptic drugs.

  2000cited by this paper
• Teratogenic Effects of Antiepileptic Drugs: Use of an International Database on Malformations and Drug Exposure (MADRE)

  2000cited by this paper
• Population based, prospective study of the care of women with epilepsy in pregnancy

  2000cited by this paper
• A clinical study of 57 children with fetal anticonvulsant syndromes

  2000cited by this paper
• Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene

  1999cited by this paper
• Need for inclusion and exclusion criteria for the structural abnormalities recorded in children born from exposed pregnancies.

  1999cited by this paper
• Malformations in Offspring of Women with Epilepsy: A Prospective Study

  1999cited by this paper
• Effect of maternal anticonvulsant treatment on neonatal blood coagulation

  1999cited by this paper
• Antiepileptic drug regimens and major congenital abnormalities in the offspring

  1999cited by this paper
• Congenital malformations due to antiepileptic drugs.

  1999cited by this paper
• A maternal complex partial seizure in labor can affect fetal heart rate

  1998cited by this paper
• Guidelines for the care of women with epilepsy

  1998cited by this paper
• Prenatal anticonvulsant drug exposure: teratogenic effect on the dentition.

  1998cited by this paper
• Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy.

  1998cited by this paper
• A male with fetal valproate syndrome and autism

  1997cited by this paper
• Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy

  1997cited by this paper
• Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications.

  1997cited by this paper
• Hand anomalies in fetal-hydantoin syndrome: from nail/phalangeal hypoplasia to unilateral acheiria.

  1996cited by this paper
• In utero exposure to phenobarbital and intelligence deficits in adult men.

  1995cited by this paper
• Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs.

  1994cited by this paper
• Epilepsy and Pregnancy: A Prospective Study of Seizure Control in Relation to Free and Total Plasma Concentrations of Carbamazepine and Phenytoin

  1994cited by this paper
• Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling Pairs

  1994cited by this paper
• Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.

  1994cited by this paper
• Lessons on objectivity in clinical studies.

  1994cited by this paper
• Supplementation of vitamin K in pregnant women receiving anti‐convulsant therapy prevents neonatal vitamin K deficiency

  1993cited by this paper
• Hydantoin syndrome with holoprosencephaly: a possible rare teratogenic effect.

  1993cited by this paper
• Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency

  1993cited by this paper
• Preaxial ray reduction defects as part of valproic acid embryofetopathy

  1993cited by this paper
• Antiepileptic drug disposition during pregnancy.

  1992cited by this paper
• The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age.

  1992cited by this paper
• Epilepsy and employment, marital, education and social status.

  1992cited by this paper
• The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.

  1992cited by this paper
• Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

  1992cited by this paper
• Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.

  1992cited by this paper
• Prospects in cardiology.

  1992cited by this paper
• Malformations in offspring of 305 epileptic women: a prospective study

  1992cited by this paper
• Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity.

  1992cited by this paper
• Spina bifida in infants of women treated with carbamazepine during pregnancy.

  1991cited by this paper
• Prevention of neural tube defects : Results of the Medical Research Council Vitamin Study MRC VITAMIN STUDY RESEARCH GROUP

  1991cited by this paper
• Sexual Behavior of a Sample of Females with Epilepsy

  1991cited by this paper
• Prenatal prediction of risk of the fetal hydantoin syndrome.

  1990cited by this paper
• SPECIFIC COGNITIVE DYSFUNCTION IN CHILDREN WITH EPILEPTIC MOTHERS

  1990cited by this paper
• Pattern of malformations in the children of women treated with carbamazepine during pregnancy.

  1989cited by this paper
• Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds.

  1989cited by this paper
• Verification of the fetal valproate syndrome phenotype.

  1988cited by this paper
• Family studies in fetal phenytoin exposure.

  1988cited by this paper
• Predictive value of minor anomalies. I. Association with major malformations.

  1987cited by this paper
• Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study

  1987cited by this paper
• Drug metabolism in pregnancy, infancy and childhood.

  1987cited by this paper
• Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens.

  1987cited by this paper
• Anticonvulsant drugs in monotherapy. Effect on the fetus

  1987cited by this paper
• Epidemiology of human reproduction.

  1986cited by this paper
• Pregnancy Complications and Outcomes in a Cohort of Women with Epilepsy

  1985cited by this paper
• Obstetric outcome in women with epilepsy.

  1985cited by this paper
• Teratogenicity of anticonvulsant drugs.

  1985cited by this paper
• Congenital Rubella Syndrome and Diabetes: A Review of Epidemiologic, Genetic, and Immunologic Factors

  1985cited by this paper
• Genetic predisposition to phenytoin-induced birth defects.

  1985cited by this paper
• Teratogenicity of anticonvulsant drugs. II: A prospective study.

  1984cited by this paper
• Maternal valproic acid and congenital neural tube defects.

  1982cited by this paper
• Fetal hydantoin syndrome.

  1981cited by this paper
• Randomised trial of high doses of stilboestrol and ethisterone therapy in pregnancy: long-term follow-up of the children.

  1981cited by this paper
• Teratogenic effects of anticonvulsants.

  1981cited by this paper
• Phenytoin-induced teratology and gingival pathology

  1980cited by this paper
• Fetal heart rate during a maternal grand mal epileptic seizure

  1979cited by this paper
• Anticonvulsant medication.

  1977cited by this paper
• Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome.

  1976cited by this paper
• Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study

  1973cited by this paper
• Diphenylhydantoin and selected congenital malformations.

  1973cited by this paper
• Dermatoglyphics in distal phalangeal hypoplasia.

  1972cited by this paper
• Maternal epilepsy and abnormalities of the fetus and newborn.

  1972cited by this paper
• Fetal growth at sea level.

  1972cited by this paper
• Anticonvulsant drugs and congenital abnormalities.

  1968cited by this paper

• Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability

  2019cites this paper
• Risks and management of pregnancy in women with epilepsy: a review

  2018cites this paper
• Antiepileptic Drugs and Foetal Malformations: A Possible Class Effect

  2016cites this paper
• Guías de prácticas clínicas para la atención y el manejo de los problemas médicos de las mujeres con epilepsia

  2013cites this paper
• Effect of Lamotrigine on fetal rat brain morphology

  2013cites this paper
• Rare but real--the effects of sodium valproate in pregnancy.

  2011cites this paper
• Monotherapy of Epilepsy in Women: Psychiatric and Neuroendocrine Aspects

  2010cites this paper
• Effects of Early Life Seizures and Anti-epileptic Drug Treatment on Human Brain Development in Human Models

  2009cites this paper
• Fetal Malformations Associated with the Use of Methylphenobarbital and Carbamazepine during Pregnancy

  2009influential citation
• Italian Consensus Conference on Epilepsy and Pregnancy, Labor and Puerperium

  2009influential citation
• Antiepileptic drugs as human teratogens.

  2008cites this paper
• The internal control group in a register of antiepileptic drug use in pregnancy.

  2008cites this paper
• Pregnancy, epilepsy, and anticonvulsants

  2008cites this paper
• Drug Class Review: Antiepileptic Drugs for Indications Other Than Epilepsy: Final Report Update 2

  2008cites this paper
• Antiepileptic drugs as human teratogens

  2008cites this paper
• Treatment options for pregnant women with epilepsy

  2008cites this paper
• The adverse effects of antiepileptic drugs in children

  2007influential citation
• Drug Class Review on Antiepileptic Drugs in Bipolar Mood Disorder, Neuropathic Pain, and Fibromyalgia

  2006cites this paper
• Seizures and Antiepileptic Drugs: Does Exposure Alter Normal Brain Development?

  2006cites this paper
• Human placental perfusion method in the assessment of transplacental passage of antiepileptic drugs.

  2005cites this paper
• Treatment options for epilepsy during pregnancy

  2005cites this paper
• FETAL ANTICONVULSANT SYNDROME

  2005cites this paper
• EUROCAT – epidemiologijsko praćenje prirođenih mana u Europi

  2005cites this paper
• Birth defects after prenatal exposure to antiepileptic drugs.

  2005cites this paper
• Approach to the patient with epilepsy in the outpatient department

  2005cites this paper
• Epilepsy: time for review.

  2003cites this paper
• In search of models for hepatic and placental pharmacokinetics

  2003cites this paper
• The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.

  2003cites this paper
• Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop.

  2003cites this paper
• The importance of monotherapy in pregnancy

  2003cites this paper